Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

FAC is trading near the bottom of its 52-week range and below its 200-day simple moving average. Price change The price of FAC shares has increased $0.21 since the market last closed. This is a 4.93% ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Recent insider activity for Recursion Pharmaceuticals Inc included 1 Tax Payment by Ben R Taylor totaling $18,400.36. 1 transaction was reported, and the full verified total matches $18,400.36.